CapsoVision, Inc.

Status: Publicly traded

Direct answer

CapsoVision, Inc. is publicly traded on NASDAQ under the ticker CV.

CapsoVision, Inc. operates as a medical technology firm, specializing in creating innovative solutions for diagnosing conditions within the gastrointestinal tract. Their offerings encompass cutting-edge capsule endoscopy systems, specifically CapsoCam Plus and CapsoCam Colon, alongside advanced artificial intelligence-driven imaging platforms.

Can you invest in CapsoVision, Inc.?

Yes. CapsoVision, Inc. is publicly traded on NASDAQ under the ticker CV.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for CapsoVision, Inc.

Detailed equity research is provided by MarketSnap.